Sponsor
Gabe Evans
Representative · R-CO
Representative · R-CO
The bill strengthens tools, coordination, and transparency to curb illegal pill production and reduce overdose risk, but does so by imposing new compliance costs, recordkeeping burdens, and expanded criminal exposure that could affect manufacturers, sellers, buyers, taxpayers, and defendants.
The general public will likely face reduced availability of equipment used to mass-produce illicit pills, which can lower illegal drug supply and reduce overdose risk.
Law enforcement and prosecutors get clearer legal definitions, tools, and penalties plus a mandated DEA operational/response plan and annual data, improving coordination, targeting, and prosecution of large-scale illicit pill production and distribution.
Hospitals, pharmacies, drug manufacturers, and other regulated businesses gain better traceability (nonremovable serial numbers, recordkeeping) and clearer compliance rules with a defined rulemaking timeline, reducing long-term regulatory uncertainty.
Owners, sellers, manufacturers, and importers of tableting/encapsulating equipment will face substantial compliance and production costs to affix nonremovable serial numbers, change labeling/production processes, and maintain records.
Secondary purchasers, brokers, and legitimate buyers face increased legal risk because possession or movement of machines with removed/altered serial numbers can carry criminal penalties, raising liability for downstream buyers.
Sellers and distributors of legitimate equipment face prosecution risk if they cannot prove buyers' lawful intent; expanded vetting, recordkeeping, and due-diligence burdens may raise prices for legitimate purchasers.
Based on analysis of 4 sections of legislative text.
Requires serial numbers, recordkeeping, and regulation of tablet/encapsulating machines and critical parts; criminalizes illicit manufacture/distribution of such equipment and mandates DEA reporting and response planning.
Treats tablet- and capsule-making machines and certain integral parts as regulated machinery, requires permanent serial numbers and expanded transaction records, and makes removing/altering serial numbers and knowingly moving altered machines unlawful. It creates new federal offenses for manufacturing, distributing, or exporting such machines or parts when the person knows or intends they will be used to make illicit controlled substances or be unlawfully imported, raises criminal penalties in certain cases, directs sentencing guideline changes, and requires the DEA to adopt an operational response plan and report annually to Congress on counterfeit pills and enforcement actions.
Official title: To amend the Controlled Substances Act to prevent the misuse of a tableting machine, encapsulating machine, or critical part of a tableting and encapsulating machine for the illicit manufacture of a controlled substance or listed chemical, and for other purposes.
Introduced March 19, 2026 by Gabe Evans · Last progress September 16, 2026